<p>Groups on 10 Balb/c mice were immunized two doses of 2.5 µg CSP, 2 months apart in the indicated adjuvant. One month post second immunization sera were collected and analyzed. <i>A,</i> ELISA end point titers of mice, measured against CS/D (left) or NANP repeat peptide (right). <i>B,</i> IgG1 (left) and IgG2a (right) subclasses expressed as Luminex mean fluorescence intensities (MFI) at 1∶500 serum dilution. <i>C</i>, Percentage of total Cytokine<sup>+</sup>CD44<sup>+</sup>CD4<sup>+</sup> T lymphocytes, extracted from vaccinated Balb/c mice and stimulated with CS/D, stained for intracellular IL-2 (left) or IFN-γ (middle) or CD8<sup>+</sup> cells stimulated with the K<sup>d</sup>-restricted peptide and stained for IFN-γ (right). Lines are...
<p>Values shown represent the reciprocal of the endpoint ELISA titer for each mouse (closed circles)...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>BALB/c mice were immunized subcutaneously with 20 µg of cED III or LcED III two times at a two-we...
<p>Groups on 15 C57Bl/6 mice were immunized with 2 doses of 2.5 µg of CSP, 3 weeks apart, in the ind...
<p>Groups of 15 C57Bl/6 mice were immunized three times, 3 weeks apart, with 2.5 µg of CSP in the in...
<p>Groups of 10 Balb/c mice were immunized with 2 doses of 2.5 µg CSP, 2 months apart in the indicat...
<p>Groups of 10 mice received 2 doses, 3 weeks apart of 2.5 μg CSP+Alum, Qβ-CSP+Alum or Qβ-CSP witho...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>Groups of 7 mice received three immunizations of 0.1, 1, 2.5, 5 or 10 µg CS/D, adjuvanted with GL...
<p>Groups of 6 mice were vaccinated thrice with 2.5, 1 and 0.1 μg CSP or Qβ-CSP in Montanide. A, B s...
<p>Naïve BALB/c mice or mice pre-immunized with two injections (1×10<sup>10</sup> pu each) of Ad5 ve...
<p>Nine BALB/c female mice per group were vaccinated three times subcutaneously with 100 μg/mouse of...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>BALB/c mice (n = 20 mice/group) were immunized with DNA or adenovectors as indicated. (A) Schemat...
<p>BALB/c mice were immunized i.m. with 1.5×10<sup>9</sup> or 1.5×10<sup>7</sup> ifu AdHu5-PyMSP1<su...
<p>Values shown represent the reciprocal of the endpoint ELISA titer for each mouse (closed circles)...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>BALB/c mice were immunized subcutaneously with 20 µg of cED III or LcED III two times at a two-we...
<p>Groups on 15 C57Bl/6 mice were immunized with 2 doses of 2.5 µg of CSP, 3 weeks apart, in the ind...
<p>Groups of 15 C57Bl/6 mice were immunized three times, 3 weeks apart, with 2.5 µg of CSP in the in...
<p>Groups of 10 Balb/c mice were immunized with 2 doses of 2.5 µg CSP, 2 months apart in the indicat...
<p>Groups of 10 mice received 2 doses, 3 weeks apart of 2.5 μg CSP+Alum, Qβ-CSP+Alum or Qβ-CSP witho...
<p>Groups of 10 mice received 3 doses, 3 weeks apart of 2.5 μg CSP+SE, Qβ-CSP+SE, CSP+GLA/SE, Qβ-CSP...
<p>Groups of 7 mice received three immunizations of 0.1, 1, 2.5, 5 or 10 µg CS/D, adjuvanted with GL...
<p>Groups of 6 mice were vaccinated thrice with 2.5, 1 and 0.1 μg CSP or Qβ-CSP in Montanide. A, B s...
<p>Naïve BALB/c mice or mice pre-immunized with two injections (1×10<sup>10</sup> pu each) of Ad5 ve...
<p>Nine BALB/c female mice per group were vaccinated three times subcutaneously with 100 μg/mouse of...
<p>BALB/c mice were immunized with recombinant Em-TSP3 at a dose of 50 µg/mouse plus adjuvant (CpG f...
<p>BALB/c mice (n = 20 mice/group) were immunized with DNA or adenovectors as indicated. (A) Schemat...
<p>BALB/c mice were immunized i.m. with 1.5×10<sup>9</sup> or 1.5×10<sup>7</sup> ifu AdHu5-PyMSP1<su...
<p>Values shown represent the reciprocal of the endpoint ELISA titer for each mouse (closed circles)...
<p>Groups of BALB/c mice were immunized 3 times i.m. (separated by 4 weeks each) with 2 different do...
<p>BALB/c mice were immunized subcutaneously with 20 µg of cED III or LcED III two times at a two-we...